A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts
A Glimpse Into The Expert Outlook On Autolus Therapeutics Through 5 Analysts
通過5位分析師的專家觀點一窺autolus therapeutics
Analysts' ratings for Autolus Therapeutics (NASDAQ:AUTL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
根據5位分析師的表示，Autolus Therapeutics（NASDAQ：AUTL）過去一季度的分析師評級從看好變成看淡不等。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $9.4, a high estimate of $11.00, and a low estimate of $9.00. This current average reflects an increase of 1.62% from the previous average price target of $9.25.
分析師分析12個月的目標價格，提供有用的信息，平均目標價格爲9.4美元，最高估價爲11.00美元，最低估價爲9.00美元。目前的平均目標價格反映了1.62％的增長自上一個平均目標價格9.25美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
In examining recent analyst actions, we gain insights into...
通過對最近的分析師...
登入免費觀看全文
登入/註冊